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Abstract 
 
 
 
 
 
 
 
Larynx cancer is one of the most susceptible form of cancer susceptible to induce 
alteration of the patient’s psychological profile due to the social role that the larynx has in 
communication. Oral communication is severely impaired even after voice rehabilitation of 
the laryngectomized patients, so that the social rehabilitation is somewhat not only a 
medical but also a social problem. The psychological profile of these patients is altered in a 
way that dealing with the disease is sometimes neglected and the interaction with the 
outside world in terms of oral communication is totally abandoned. The starting point for 
depression in these cases is the acknowledgement of the disease and is, in some cases, the 
entire medical environment. Facial scarring, the inability to verbally interact with other 
human, as well as the presence of the tracheostoma, are all deciding factors in the presence 
of a low self-esteem for these particular patients. Psychological counseling is a mandatory 
approach for laryngectomized patients, in order to improve their ability to cope with cancer 
and providing better recovery chances. 
  
Keywords: depression, self-esteem, total laryngectomy, social rehabilitation 
 Laringectomy and psychological profile 
32 
 
Introduction  
Head and neck malignant neoplasia is one of 
the most important public health issues mainly due 
to the increasing incidence in the last two decades. 
The increasing number of the patients that present 
to the E.N.T. specialist is closely linked to the 
tobacco and alcohol consumption. There is a way 
to describe the regular larynx cancer patient in 
regards to social status and comorbidities, namely 
the archetype being male, old, multiple 
comorbidities and associating the consumption of 
high quantities of tobacco and alcohol (1, 2). 
Never the less poor health status and comorbidities 
are risk factors that are presenting most head and 
neck malignant neoplasia patients. Larynx cancer 
is the second most involved site of the airway tract 
after the lungs. The population that presents with 
this type of malignancy in dominated by the male 
sex, although there is evidence of increased 
incidence of larynx cancer in women. The 
particularity of larynx cancer patients in Romania 
is that certain categories of people such as 
minorities and low social and economic status 
individuals usually present themselves to the 
physician in late stages of disease. The associated 
comorbidities and the impaired biological status 
means that the survival rates in this category of 
patients is lower than average for the same stage. 
This has been documented in several studies (3, 4). 
Poor socio-economic status comes with an 
impaired psychological profile. This is either due 
to the fact that the physical condition is caused by 
the personal habits or due to the fact that the 
malignancy leads to psychological changes. In 
either cases most patients that present themselves 
to the physician in such late stage larynx cancer 
have anxiety issues, low self-esteem, depression in 
various stages and a lack of will.  
If the oncologic diagnostic work-up indicates 
that surgery is viable, patients with late stages of 
larynx cancer benefit from total laryngectomy. 
Although surgery is preferred in our department, 
the Oncology Committee might refer the patient to 
undergo radiation therapy first followed by salvage 
surgery in case of no remission or a combination of 
radiation therapy, chemotherapy and surgery (1, 5). 
All patients that are admitted in our department 
undergo total laryngectomy for late stage larynx 
cancer. This type of surgery is a complex 
procedure in terms of preparation, work-up and 
follow-up from patient’s perspective. The removal 
of the larynx debilitates the patient in terms of 
senses and aesthetics. 
The complexity of multimodal therapy for 
late stage cancer patients is linked to a multitude of 
side effects, some as a result of surgery such as 
impaired functioning of swallowing, breathing, 
speech, taste, smell, decreased sensitivity of the 
cervical and facial region, facial disfigurement, 
and some as a result of radiotherapy and/or 
chemotherapy such as swelling, mucositis, residual 
pain, alteration of skin, burning sensations (6, 7). 
All of these side effects have a tendency to limit 
the social reinsertion of larynx cancer patients. 
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Most of the patients never work again due to their 
handicap and those who do are usually unable to 
return to their workplaces or perform some other 
tasks for a long period of time after finishing all 
oncology therapies (8, 9). 
Multimodal therapy for oncology patients, in 
our case larynx cancer patients, requires a 
thorough assessment of the quality of life. Several 
instruments have been used for this goal each for 
specific conditions, such as the Head and Neck 
Cancer Inventory (10) and survey forms included 
in the head and neck cancer module of the 
European Organization for Research and 
Treatment of Cancer (11). These instruments are of 
outmost importance in order to better assess the 
psychosocial variables and include each patient in 
particular classes of stress. The clear delimitation 
of these groups is subject for clinical intervention 
to improve the quality of life for larynx cancer 
patients (12, 13). 
Work-up 
Several studies have analyzed the recovery 
status for larynx cancer patients that survived 
multimodal oncology therapy. These studies 
indicate that the quality of life reaches its lowest 
endpoint during therapy and for a limited period of 
time lapsed afterwards. From this point on most 
patients show significant improvement right up to 
the baseline level. The baseline level as compared 
to a non-cancer patient is usually reached 
approximately twelve months after diagnosis (10, 
14-16). 
Psychological impairment 
The psychological profile of the larynx 
cancer patient is different from that of other cancer 
patients mostly due to the fact that facial scarring 
is subject of daily observation by the patient. This 
is a reminder of the disease for the patient that 
triggers a series of conflictual emotions. The 
disturbing experience for these patients is 
translated into a clinical or subclinical depression, 
significant psychological impairment being visible 
in patients that have a great amount of anxiety 
prior to the treatment. Symptoms of subclinical 
depression or the full manifestation of a depression 
syndrome are to be expected in cancer patients and 
may be present after oncology therapy even 
months or years afterwards (17, 18). Depression is 
in most cases a multifactorial condition and it is 
characterized by the interaction of the diagnosis, 
the burden of the disease, financial reasons, 
treatment sequelae, social restrictions, 
dysfunctional family life, and the possibility of 
recurrence or death. Moreover, patients appreciate 
the quality of life by the intake of food and 
beverages and the ability to speak. All these factors 
lead to a more likely depression syndrome for 
larynx cancer patients than any other cancer 
patients (17). 
The recurrence of the disease is a major 
setback in the psychological profile of larynx 
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cancer patients and in most cases it is the trigger 
for stopping all oncology therapy. Those patients 
who decide to continue oncology therapy relate at 
a personal level with their surgeon. This type of 
patient-physician relationship is essential for the 
coping mechanism of these patients. Trust is a key 
element in the patient-physician relationship and 
should be earned by the physician by using 
appropriate bedside manners. 
A large number of studies have been 
conducted to evaluate depression levels in cancer 
patients and particular for head and neck cancer 
patients. Howren and colleagues concluded in 
2010 that subclinical depression symptoms present 
prior to the beginning of oncology therapy was 
linked to a lower quality of life one year after the 
conclusion of therapy when comparing values with 
known baseline indicators. The same poorer 
quality of life in associated with other factors such 
as age, gender, socio-economic status, 
comorbidities and the consumption of tobacco and 
alcohol. 
Some authors indicate that patients with 
increased levels on anxiety are more likely to refer 
to their disease as debilitating including disease-
specific intrusion and avoidance. Despite these 
indicators the group of patients with high levels of 
anxiety that manifest distress symptoms and home 
healthcare assistance did not differ significantly 
from the group of patients with less anxiety (19). 
Tobacco and alcohol addiction 
The consumption of tobacco and alcohol 
alone or in association is incriminated in the 
appearance of human malignancies. It is the case 
of larynx cancer for which the association of the 
two increases the risk of developing this type of 
cancer 10 folds. We appreciate that as much as 
95% of our patients have a history of consuming 
tobacco and/or alcohol. Tobacco and alcohol 
cessation is the most important behavior 
modification that larynx cancer patients need to do. 
This is one of the most important problems in post-
therapy period. Continued smoking negatively 
affects treatment efficacy and survival (20- 22). 
The involvement of the pharynx mucosa is affected 
by the consumption of alcohol and the mucosa of 
the trachea is affected by continued smoking in 
terms of worsening the mucositis present after 
adjuvant radiotherapy or chemotherapy. Smoking 
and alcohol consumption increases edema and 
chronic inflammation. Therefore, severe mucositis 
is a cause of therapy interruption and further 
hospitalizations (23). Patients with total 
laryngectomy smoke through the tracheal tube. In 
terms of secretions this habit increases the quantity 
of mucus which may be a cause for tracheal or 
lung infections which also leads to increased 
morbidity and hospitalization. 
Data from several studies indicate that as 
much as 50% or more head and neck cancer 
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patients continue to consume tobacco and/or 
alcohol after diagnosis and after conclusion of 
oncology therapy (24- 26). This behaviour is 
subject to clinical behaviour medicine in which 
specialist need to intervene because some patients 
are unawarethat tobacco and alcohol consumption 
may lead to recurrence or a second malignancy in 
the head and neck region. Facing with a life-
altering diagnosis and potentially aworse outcome, 
some patients with cancer ofhead and neck 
consider the cessation of tobacco and alcohol 
consumption unnecessary and tend to address their 
addictions for a better short term quality of life 
(27- 29). 
 
Conclusions 
Larynx cancer patients are subject to 
psychological impairment with subclinical 
depression or clinical present symptoms due to the 
severity of the disease and the complexity of the 
oncology therapy. The quality of life for patients 
that survive needs to be assessed by using 
condition-specific instruments to establish the need 
for psychological support in each patient. 
Professional healthcare givers are those who 
interact with larynx cancer patients and need to 
pay attention to each patient’s needs. Further 
studies need to be conducted in larynx cancer 
patients that undergo surgery and the use of 
psychometric instruments is necessary. 
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